Navamedic
Develops, produces, and commercializes medicines and related health products.
NAVA | OL
Overview
Corporate Details
- ISIN(s):
- NO0010205966
- LEI:
- 529900LKVQOR2SRUJU71
- Country:
- Norway
- Address:
- Henrik Ibsens gate 100, 0255 OSLO
- Website:
- https://navamedic.com/
- Sector:
- Wholesale and retail trade
- Industry:
- Other specialized wholesale
Description
Navamedic is a pharmaceutical company that develops, produces, and commercializes a diverse portfolio of medicines and related health products. The company's offerings include specialty pharmaceuticals, branded generics, and consumer health items. Its product portfolio addresses various medical needs, with treatments for conditions such as obesity, Parkinson's disorder, and inborn errors of metabolism, in addition to antibiotics. Serving as a reliable supplier and distribution partner, Navamedic provides high-quality products to hospitals and pharmacies, with a strong presence in the Nordic region and the Netherlands. The company focuses on improving patient outcomes through innovations, including advancements in personalized treatment for Parkinson's care.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2024-11-19 09:43 |
Flaggemelding Navamedic (NAVA)
|
Norwegian | HTML • 502 bytes | ||
| 2024-11-15 12:00 |
Navamedic ASA: Amendments to loan agreements with Observe Medical ASA
|
English | HTML • 4.3 KB | ||
| 2024-11-06 12:52 |
Navamedic ASA: Mandatory notice of trade
|
English | PDF • 63.4 KB | ||
| 2024-11-06 12:52 |
Navamedic ASA: Mandatory notice of trade
|
English | HTML • 862 bytes | ||
| 2024-11-06 08:10 |
Navamedic launches Eroxon[®] in Finland
|
English | HTML • 4.1 KB | ||
| 2024-10-31 06:00 |
Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical natu…
|
English | PDF • 4.3 MB | ||
| 2024-10-31 06:00 |
Navamedic 3. kvartal 2024: Fortsatt solide resultater i et kvartal som er prege…
|
English | PDF • 4.3 MB | ||
| 2024-10-31 06:00 |
Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical natu…
|
English | HTML • 6.7 KB | ||
| 2024-10-31 06:00 |
Navamedic 3. kvartal 2024: Fortsatt solide resultater i et kvartal som er prege…
|
Norwegian | HTML • 6.8 KB | ||
| 2024-10-28 08:09 |
Navamedic ASA: Invitation to 2024 3rd quarter presentation
|
English | HTML • 1.5 KB | ||
| 2024-10-07 11:57 |
Navamedic wins joint Nordic antibiotics tender
|
English | HTML • 2.8 KB | ||
| 2024-09-19 06:24 |
Navamedic ASA - Registration of share capital increase
|
English | HTML • 1.7 KB | ||
| 2024-09-12 10:00 |
Navamedic announces an exclusive agreement with Alex Therapeutics for the devel…
|
English | HTML • 3.9 KB | ||
| 2024-09-09 14:48 |
Navamedic ASA - Mandatory notification of trade by primary insider
|
English | PDF • 126.8 KB | ||
| 2024-09-09 14:47 |
Navamedic ASA - Mandatory notification of trade by primary insider
|
English | HTML • 2.1 KB |
Automate Your Workflow. Get a real-time feed of all Navamedic filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Navamedic
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Navamedic via our API.
Peer Companies
